Predictions
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€736.80
23.03.23
23.03.23
€791.57
23.03.24
23.03.24
20.86%
24.03.24
24.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€307.70
13.03.23
13.03.23
€350.10
13.03.24
13.03.24
124.73%
14.03.24
14.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€299.80
03.03.23
03.03.23
€339.30
03.03.24
03.03.24
142.83%
04.03.24
04.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€239.95
01.04.22
01.04.22
€330.00
18.12.23
18.12.23
41.68%
14.11.23
14.11.23
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€337.60
09.04.23
09.04.23
€362.00
09.10.23
09.10.23
57.73%
09.10.23
09.10.23
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€502.50
17.08.23
17.08.23
€510.00
17.08.24
17.08.24
10.75%
13.09.23
13.09.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Johnson & Johnson
Start price
Target price
Perf. (%)
€152.60
24.07.23
24.07.23
€155.00
24.07.24
24.07.24
3.47%
16.08.23
16.08.23
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€100.76
08.08.22
08.08.22
€120.00
08.08.23
08.08.23
69.31%
09.08.23
09.08.23
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€388.00
05.05.23
05.05.23
€395.00
05.05.24
05.05.24
3.52%
12.05.23
12.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Seagen Inc.
Start price
Target price
Perf. (%)
€165.90
15.08.22
15.08.22
€180.00
31.01.24
31.01.24
9.64%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year